碘125放射性粒子植入近距离治疗不可切除胰腺癌的现状与进展
| 作者: |
1罗东,
1唐能,
1刘国栋,
1杨杰,
1纪连栋,
1柯牧京,
1欧政林,
1李宜雄
1 中南大学湘雅医院 普通外科，湖南 长沙 410008 |
| 通讯: |
李宜雄
Email: liyixiong2011@hotmail.com |
| DOI: | 10.3978/.10.3978/j.issn.1005-6947.10.3978/j.issn.1005-6947.2017.09.018 |
摘要
碘125（125I）放射性粒子植入近距离治疗不可切除胰腺癌近年来新兴的一种胰腺癌治疗技术，临床实践显示，它对胰腺癌患者的疼痛缓解、肿瘤进展控制、生活质量改善、生存时间延长等方面具有良好疗效。笔者就125I放射性粒子近距离植入治疗不可切除胰腺癌的现状与进展进行综述。
关键词：
胰腺肿瘤
碘放射性同位素
近距离放射疗法
综述文献
Iodine-125 radioactive seed implantation brachytherapy for unresectable pancreatic cancer: current status and progress
CorrespondingAuthor:LI Yixiong Email: liyixiong2011@hotmail.com
Abstract
Iodine-125 (125I) radioactive seed implantation brachytherapy is an emerging technique to treat pancreatic cancer, which, shown by clinical practice, offers benefits for pancreatic cancer patients in terms of pain relief, tumor progression control, quality of life improvement and survival time prolongation. Here, the authors present the current status and progress of 125I radioactive seed implantation brachytherapy in treatment of unresectable pancreatic cancer.
Keywords：
Pancreatic Neoplasms
Iodine Radioisotopes
Brachytherapy
Review